Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic pain | D059350 | HP_0012532 | — | — | 2 | 2 | — | — | 4 |
Pain | D010146 | EFO_0003843 | R52 | 1 | 1 | 2 | — | — | 4 |
Neoplasms | D009369 | — | C80 | — | — | 2 | — | — | 2 |
Acute pain | D059787 | — | R52 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic neuropathies | D003929 | EFO_1000783 | — | — | 3 | — | — | — | 3 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 2 | — | — | — | 2 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 2 | — | — | — | 2 |
Polyneuropathies | D011115 | EFO_0009562 | A69.22 | — | 2 | — | — | — | 2 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 1 | — | — | — | 1 |
Low back pain | D017116 | HP_0003419 | M54.5 | — | 1 | — | — | — | 1 |
Back pain | D001416 | HP_0003418 | M54 | — | 1 | — | — | — | 1 |
Postoperative pain | D010149 | — | G89.18 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 2 | — | — | — | — | 2 |
Hypercapnia | D006935 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Cebranopadol |
INN | cebranopadol |
Description | Cebranopadol (developmental code GRT-6005) is an opioid analgesic of the benzenoid class which is currently under development internationally by Grünenthal, a German pharmaceutical company, and its partner Depomed, a pharmaceutical company in the United States, for the treatment of a variety of different acute and chronic pain states. As of November 2014, it is in phase III clinical trials.
|
Classification | Small molecule |
Drug class | analgesics (mixed opiate receptor agonists/antagonists) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12 |
PDB | — |
CAS-ID | 863513-91-1 |
RxCUI | — |
ChEMBL ID | CHEMBL2364605 |
ChEBI ID | — |
PubChem CID | 11848225 |
DrugBank | DB12830 |
UNII ID | 7GDW9S3GN3 (ChemIDplus, GSRS) |